Board of Directors
Dr. Jan Groen
Chairman of the board. Jan Groen has an impressive track record of building several successful commercial diagnostic companies in both Europe and the USA with a focus on emerging technologies, product development and commercialization.
Prof Dr. Wim van Criekinge
Wim van Criekinge is Professor in Computational Genomics and Bioinformatics at Ghent University within the faculty of Bioscience Engineering. He brings over 20 years of experience in the life sciences industry as a strategic, scientific consultant and business executive in diagnostic and biotech companies.
Maaike van Min, MA
Maaike has a strong international background in strategy, development, and building and maintaining external partnerships.
Scientific Advisory Board
Prof. Dr. Wouter de Laat
Wouter de Laat studied biology at the Utrecht University and received a PhD in molecular biology at the Erasmus University Rotterdam. He develops and pioneers the use of 3C technologies in DNA diagnostics and research, aimed to understand the structure and function of the genome. Professor De Laat is co-inventor of the TLA technology, group leader at the Hubrecht Institute in Utrecht and Professor in Biomedical Genomics at the University Medical Center Utrecht.
Prof. Dr. Han Brunner
Han Brunner is a professor and Head of the Department of Human Genetics at the Radboud University in Nijmegen. He has served on the board of the Dutch Human Genetics Society and as chairman of the Scientific Program Committee of the European Society of Human Genetics. Han Brunner is the president-elect of the European Society of Human Genetics.
Prof. Dr. Frank Grosveld
Frank Grosveld is a professor at the Dutch National Academy of Sciences (KNAW) and a fellow of the Royal Society. He is head of the Cell Biology Department at the Erasmus MC and former interim head of its Clinical Genetics Department.
Prof. Dr. Sabine Linn
Sabine Linn is a group leader at the Netherlands Cancer Institute and Professor of Translational Oncology at the University Medical Center Utrecht. She specializes in the molecular mechanisms underlying drug sensitivity and the development of personalised medicine.